Tie J - Search Results

1

Real-world adjuvant chemotherapy treatment patterns and outcomes over time for resected stage II and III colorectal cancer.

To YH, Degeling K, McCoy M, Wong R, Jones I, Dunn C, Hong W, Loft M, Gibbs P, Tie J. To YH, et al. Among authors: tie j. Asia Pac J Clin Oncol. 2023 Jun;19(3):392-402. doi: 10.1111/ajco.13885. Epub 2022 Dec 4. Asia Pac J Clin Oncol. 2023. PMID: 36464923

2

Optimizing targeted therapeutic development: analysis of a colorectal cancer patient population with the BRAF(V600E) mutation.

Tie J, Gibbs P, Lipton L, Christie M, Jorissen RN, Burgess AW, Croxford M, Jones I, Langland R, Kosmider S, McKay D, Bollag G, Nolop K, Sieber OM, Desai J. Tie J, et al. Int J Cancer. 2011 May 1;128(9):2075-84. doi: 10.1002/ijc.25555. Int J Cancer. 2011. PMID: 20635392 Free article.

3

KRAS mutation is associated with lung metastasis in patients with curatively resected colorectal cancer.

Tie J, Lipton L, Desai J, Gibbs P, Jorissen RN, Christie M, Drummond KJ, Thomson BN, Usatoff V, Evans PM, Pick AW, Knight S, Carne PW, Berry R, Polglase A, McMurrick P, Zhao Q, Busam D, Strausberg RL, Domingo E, Tomlinson IP, Midgley R, Kerr D, Sieber OM. Tie J, et al. Clin Cancer Res. 2011 Mar 1;17(5):1122-30. doi: 10.1158/1078-0432.CCR-10-1720. Epub 2011 Jan 14. Clin Cancer Res. 2011. PMID: 21239505

4

Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer.

Tran B, Kopetz S, Tie J, Gibbs P, Jiang ZQ, Lieu CH, Agarwal A, Maru DM, Sieber O, Desai J. Tran B, et al. Among authors: tie j. Cancer. 2011 Oct 15;117(20):4623-32. doi: 10.1002/cncr.26086. Epub 2011 Mar 31. Cancer. 2011. PMID: 21456008 Free PMC article.

5

Microsatellite instability status is critical to analysis of survival in stage II colon cancer.

Bae S, Tie J, Desai J, Gibbs P. Bae S, et al. Among authors: tie j. J Clin Oncol. 2012 Feb 20;30(6):675-6; author reply 676-7. doi: 10.1200/JCO.2011.39.7000. Epub 2012 Jan 9. J Clin Oncol. 2012. PMID: 22231047 No abstract available.

6

Treatment with unfunded drugs in oncology: the impact of access programmes and clinical trials.

Tie J, Gibbs P. Tie J, et al. Intern Med J. 2013 Jan;43(1):23-31. doi: 10.1111/j.1445-5994.2012.02750.x. Intern Med J. 2013. PMID: 22372920 Review.

7

Second primary colorectal cancer in the era of prevalent screening and imaging.

Bae S, Asadi M, Jones I, McLaughlin S, Bui A, Steele M, Tie J, Gibbs P. Bae S, et al. Among authors: tie j. ANZ J Surg. 2013 Dec;83(12):963-7. doi: 10.1111/ans.12136. Epub 2013 Mar 26. ANZ J Surg. 2013. PMID: 23528160

8

PIK3CA and PTEN gene and exon mutation-specific clinicopathologic and molecular associations in colorectal cancer.

Day FL, Jorissen RN, Lipton L, Mouradov D, Sakthianandeswaren A, Christie M, Li S, Tsui C, Tie J, Desai J, Xu ZZ, Molloy P, Whitehall V, Leggett BA, Jones IT, McLaughlin S, Ward RL, Hawkins NJ, Ruszkiewicz AR, Moore J, Busam D, Zhao Q, Strausberg RL, Gibbs P, Sieber OM. Day FL, et al. Among authors: tie j. Clin Cancer Res. 2013 Jun 15;19(12):3285-96. doi: 10.1158/1078-0432.CCR-12-3614. Epub 2013 Apr 30. Clin Cancer Res. 2013. PMID: 23633456

9

Developing a national database for metastatic colorectal cancer management: perspectives and challenges.

Field K, Wong HL, Shapiro J, Kosmider S, Tie J, Bae S, Yip D, McKendrick J, Nott L, Desai J, Harold M, Lipton L, Stefanou G, Lim L, Parente P, Gibbs P. Field K, et al. Among authors: tie j. Intern Med J. 2013 Nov;43(11):1224-31. doi: 10.1111/imj.12230. Intern Med J. 2013. PMID: 23834128

10

Author reply: To PMID 22372920.

Tie J, Gibbs P. Tie J, et al. Intern Med J. 2013 Jul;43(7):844-5. doi: 10.1111/imj.12186. Intern Med J. 2013. PMID: 23841774 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

291 results

Search Page